The menopause nobody prepared you for

The weight that shows up in your forties, seemingly overnight, isn't a willpower story. It's a hormone story — and the research is finally starting to treat it like one.

Somewhere around forty-two, a lot of women meet a version of their body they weren't warned about. The same food, the same movement, the same effort — and the weight settles differently, mostly around the middle, and doesn't come off the way it used to. The usual advice arrives on schedule: eat less, move more, and probably a comment about slowing down. As if the problem were you being lazier than you were at thirty.

It isn't. As estrogen falls in perimenopause and menopause, the body's whole metabolic setup shifts — where fat is stored, how insulin behaves, how hunger is regulated. The weight change is a symptom of a hormonal transition, not a character update. Naming that correctly matters, because for years women have been handed the willpower explanation for what is actually an endocrine one.

What the newer research is showing

Here's the encouraging part. There'd been an assumption that GLP-1 medications might work less well once hormones shifted. The evidence is pushing back on that. Recent reviews and clinical data suggest women in perimenopause and menopause lose meaningful weight on these medicines — in the same ballpark as younger women, with tirzepatide studies showing roughly 20% reductions across reproductive stages. Menopause, it turns out, doesn't put you at the back of the line.

The weight change is a symptom of a hormonal transition, not a character update.

The hormone-therapy thread worth watching

The most interesting frontier is how GLP-1 medicines and menopausal hormone therapy might interact. Researchers are actively studying whether the two work better together than either alone — the idea being that treating the hormonal shift and the metabolic one at the same time could be more effective than tackling one and ignoring the other. This is still emerging science, so we'll resist the temptation to hand you a headline number. But the direction of the questions being asked is genuinely promising, and it's the first time in a while that midlife women's metabolism is getting serious research attention.

Why this connects to everything else we write

The thread running through PMOS (PCOS), endometriosis and menopause is the same one: women's weight gets blamed on discipline when the real story is hormonal and metabolic. A nineteen-year-old with PMOS (PCOS) and a forty-five-year-old in perimenopause have both, at some point, been told to try harder — when what they needed was someone to look at the endocrinology. The details differ. The dismissal rhymes.

That's why the kind of care matters as much as the medication. A provider who understands midlife metabolism will talk about hormones, insulin, and the whole picture — not just hand you a number to hit. If you're weighing options, that's what the comparison is for: finding people who take the whole transition seriously.

If your forties surprised you

You didn't get lazy. Your hormones changed, and your metabolism changed with them, and almost nobody sat you down and explained it. The science is catching up to what your body already told you. Find a clinician who'll treat the transition as the physiological event it is — and, as ever, go a little easier on yourself while you do.

The honest disclaimer. This is general information from the women who write Selene — not medical advice, not a recommendation, and not a promise of what will happen for you. Weight, hormone therapy, and GLP-1 medicines in menopause are individual clinical matters; please decide them with a licensed clinician who knows your history, not with a website. Results vary and no single story is typical. Selene is editorial — we don't prescribe, sell, or dispense anything.

← More from the Journal